Lourdes Health System received no infected NECC steroid products
Thursday, November 1, 2012
As reported earlier this month, three steroid injection products produced by the New England Compounding Center (NECC) are under investigation for their connection to an outbreak of meningitis. Lourdes Health System has not purchased any of the products implicated in the outbreak. Steroid injection products required for patient care are obtained from other sources.
In compliance with FDA recommendations, Lourdes has also removed all NECC products from their stock. The product purchased at Lourdes Medical Center of Burlington County (Willingboro) was methacholine inhalation solution. Products purchased at Our Lady of Lourdes Medical Center (Camden) were hydroxyprogesterone caproate IM injection and progesterone suppositories. Lourdes Emergency Department at Deborah purchased LET-gel. None of these drugs are implicated in the meningitis outbreak, but as a precaution, they are no longer being used.
Patient safety is our number one priority. If you have a concern about your care, we advise you to contact your physician directly. For questions, call 856-757-3910 or email us at firstname.lastname@example.org.